Results 171 to 180 of about 12,561 (235)

Anti-PD-1-induced bullous pemphigoid in a renal transplant recipient. [PDF]

SAGE Open Med Case Rep
Barnawi G, Kpata AJ, Aldibane R, Kashkari S, Lazarowitz R, Khanna M.   +5 more
europepmc   +1 more source

Autoimmunity to Collagen XVII (BP180-Ag2) in Pemphigoid Associated With Parkinson's Disease. [PDF]

Case Rep Dermatol Med
Cid-Puente R, Ornelas-Ramírez IG, González-Herrera L, Bollain-Y-Goytia JJ, Avalos-Diaz E, Herrera-Esparza R.   +5 more
europepmc   +1 more source

Early-onset gestational pemphigoid in the first trimester: a diagnostic pitfall. [PDF]

Pathologica
Di Lorito A, Giuliani F, Morea E, Capo A, Amerio P.   +4 more
europepmc   +1 more source

Omalizumab in the management of bullous pemphigoid: a six-month retrospective study. [PDF]

Postepy Dermatol Alergol
Ürün M, Yılmaz ÇE, Ürün YG.
europepmc   +1 more source

Bullous Diseases in the Perioperative Setting: Anesthetic Considerations. [PDF]

Cureus
Bokaee SA, Patel A.
europepmc   +1 more source

Ramipril-Induced Annular Bullous Pemphigoid: A Clinical Mimic of Linear IgA Dermatosis. [PDF]

Eurasian J Med
Karaca Ural Z.
europepmc   +1 more source

Dupilumab treatment outcomes in bullous pemphigoid: a systematic review and single-arm meta-analysis. [PDF]

Front Immunol
Chen Y, Sun K, Chang J.
europepmc   +1 more source

The Role of Accessible Hematological Markers in Bullous Pemphigoid: A Systematic Review. [PDF]

Int J Mol Sci
Małolepsza A, Juczyńska K, Woźniacka A, Brzeszczyńska J, Żebrowska A.   +4 more
europepmc   +1 more source

A Specific Signature of Circulating Free Fatty Acid Discriminates Bullous Pemphigoid From Pemphigus Vulgaris and Healthy Controls. [PDF]

Exp Dermatol
Baldi S, Bertorello S, Cei F, Nannini G, Menicatti M, Niccolai E, Bartolucci G, Baffa ME, Pipitò C, Antiga E, Amedei A, Maglie R.   +11 more
europepmc   +1 more source

Autoimmune Bullous Diseases: Therapeutic Update. [PDF]

Drugs
Kasperkiewicz M, van Beek N, Schmidt E.
europepmc   +1 more source